Poniard Pharmaceuticals News
Most Popular Poniard Pharmaceuticals Story
Struggling Poniard lays off more workers as it ponders options
Faced with the fallout from a disastrous Phase III failure for its cancer drug picoplatin last fall, a struggling Poniard Pharmaceuticals (PARD) announced another big restructuring effort this Read more...
Latest Headlines
- June 23, 2011
- February 4, 2010
- January 25, 2010
- November 17, 2009
- November 16, 2009
- August 20, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
